(51a) The Compression and Compaction Behaviour of Pharmaceutical Powders and Their Binary Mixtures
World Congress on Particle Technology
2018
8th World Congress on Particle Technology
Applications of Particle Technology for Pharmaceuticals
Recent Developments in the Characterization of Pharmaceutical Materials I
Tuesday, April 24, 2018 - 8:15am to 8:38am
Furthermore, it is well known that different micro-processes occur during powder compaction [3â6]. At the beginning of the powder compaction and thus, at low compression stresses, particle rearrangement is the main deformation mechanism and causes the reduction of inter-particulate pores due to the filling of large pores. The increase of compaction stress leads to the elastic and plastic deformation as well as fragmentation of single particles, which, in addition influences the contact area and the number of contacts between the particles. Additionally, elastic deformation of the molecule lattice occurs and causes the decrease of solids volume and thus, an increase of solids density with rising compression stress [7â9]. This phenomenon is referred to as solids compressibility. The different deformation mechanisms do not appear successively, but appear in parallel. The proportions of the single mechanisms differ in dependence on the used materials and process parameters and a differentiation between the mechanisms during the process is difficult or rather impossible. At the decompression phase, elastic recovery of the particles takes place and can lead to the destruction of weak inter-particulate bonds and to the occurrence of capping and lamination phenomena [6; 10; 11].
The missing physical process understanding requires the comprehensive characterization of the compressibility and compactibility of raw materials and the derivation of characteristic material parameters enables a more valid prediction of formulation and process development. The compressibility of a powder can be described by the relation between volume or porosity decrease and compaction stress [4]. Instrumented tablet presses enable the determination of this relationship directly during the compaction process (in-die). Various mathematical models for the description of this relation were developed, such as the models of Heckel, of Kawakita and of Cooper and Eaton [12â14]. Nonetheless, these models are mostly empirical and often describe only one part of the compaction process. Additionally, the existing mathematical models do not consider the phenomenon of solids compressibility.
In this work, the compressibility and compactibility of pharmaceutical powders with different deformation behaviour were investigated using in and out-die analysis. The compaction experiments were performed using the compaction simulator StylâOne Evolution (MedelâPharm, France), which is a single station tablet press instrumented with force and displacement sensors. Furthermore, the compression and compaction behaviour of binary powder mixtures, consisting of an active pharmaceutical ingredient (API) and an excipient, were investigated under systematic variation of the API concentration. Additionally, a new process function for the description of the in-die compression curves was developed based on mechanistic considerations and their applicability for pharmaceutical powders with different deformation behaviour as well as for binary powder mixtures, was examined. It is found that the new process function is applicable for all model materials and well suited for the derivation of characteristic material parameters. The characteristic material parameters can facilitate formulation and process development.
References
[1] F. Podczeck, M. Sharma, The influence of particle size and shape of components of binary powder mixtures on the maximum volume reduction due to packing, Int. J. Pharm. 137, 41â47.
[2] K.C. Tye, C. Sun, G.E. Amidon, Evaluation of the effects of tableting speed on the relationships between compaction pressure, tablet tensile strength, and tablet solid fraction, J. Pharm. Sci. 94, 465â472.
[3] E.N. Hiestand, J.E. Wells, C.B. Peot, J.F. Ochs, Physical Processes of Tableting, J. Pharm. Sci. 66, 1977, 510â519.
[4] H. Leuenberger, B.D. Rohera, Fundamentals of Powder Compression. I. The Compactibility and Compressibility of Pharmaceutical Powders, Pharm. Res. 3, 1986, 12â22.
[5] P. E. Wray, The Physics of Tablet Compaction revisited, Drug Dev. Ind. Pharm. 18, 1992, 627â658.
[6] D. Train, An investigation into the compaction of powders, JPP. 8, 1956, 745â761.
[7] S.N. Vaidya, G.C. Kennedy, Compressibility of 18 Molecular Organic Solids to 45 kbar, J. Chem. Phys. 55, 987â992.
[8] S. Pedersen, H.G. Kristensen, Change in crystal density of acetylsalicylic acid during compaction, S.T.P. Pharm. Sci. 4, 1994, 201â206.
[9] E.V. Boldyreva, High-pressure diffraction studies of molecular organic solids. A personal view, Acta Cryst. A64, 218â231.
[10] S.K. Dwivedi, R.J. Oates, A.G. Mitchell,
[11] J.S.M. Garr, M.H. Rubinstein, An investigation into the capping of paracetamol at increasing speeds of compression, Int. J. Pharm. 72, 117â122.
[12] A.R. Cooper, L.E. Eaton, Compaction behaviour of several ceramic powders, J. Am. Ceram. Soc. 45, 1962, 97â101.
[13] R.W. Heckel, Density-Pressure Relationships in Powder Compaction, Trans. Metall. AIME. 221, 1961, 671â675.
[14] K. Kawakita, K.-H. Lüdde, Some considerations on powder compression equations, Powder Technology. 4, 61â68.